Clinical Trial Detail

NCT ID NCT03271372
Title Adjuvant Avelumab in Merkel Cell Cancer (ADAM)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements no
Sponsors University of Washington
Indications

Merkel cell carcinoma

Therapies

Avelumab

Age Groups: adult senior

No variant requirements are available.